Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription 20.05.2024 1 Am J Pathol 1 Biochem Biophys Res Commun 2 BMC Cancer 3 BMC Gastroenterol 2 Br J Surg 1 Cancer Res 2 Dig Dis Sci 1 Endoscopy 1 Gastroenterology 3 Gut 16 Hepatology 1 Indian J Gastroenterol 1 J Clin Oncol 1 J Comput Assist Tomogr 1 J Gastroenterol Hepatol 20 J Hepatol 1 N Engl J Med 2 PLoS One 3 Radiology 1 Semin Liver Dis 1 Transplant Proc 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. ZHANG Y, Liu Y, Huo W, He L, et al
   The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases.
   Am J Pathol. 2024;194:879-893.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

2. ZHANG S, Gao YF, Zhang K, Deng GR, et al
   Integrating network pharmacology and experimental validation reveals therapeutic effects of D-mannose on NAFLD through mTOR suppression.
   Biochem Biophys Res Commun. 2024;715:149999.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. QIN Y, Tang C, Li J, Gong J, et al
   Liver cancer in China: the analysis of mortality and burden of disease trends from 2008 to 2021.
   BMC Cancer. 2024;24:594.
   PubMed         Abstract available
   
   
4. XIAO Y, Deng W, Luo L, Zhu G, et al
   Beneficial effects of maintaining liver function during hepatic arterial infusion chemotherapy combined with tyrosine kinase and programmed cell death protein-1 inhibitors on the outcomes of patients with unresectable hepatocellular carcinoma.
   BMC Cancer. 2024;24:588.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

5. ZHANG Q, Yu T, Tan H, Shi H, et al
   Hepatic recruitment of myeloid-derived suppressor cells upon liver injury promotes both liver regeneration and fibrosis.
   BMC Gastroenterol. 2024;24:163.
   PubMed         Abstract available
   
   
6. GUO Y, Dong S, Li M, Tao Y, et al
   A new model of portal vein thrombosis in rats with cirrhosis induced by partial portal vein ligation plus carbon tetrachloride and intervened with rivaroxaban.
   BMC Gastroenterol. 2024;24:161.
   PubMed         Abstract available
   
   
7. CHEN X, Fu L, Zhu Z, Wang Y, et al
   Exploring the association between dietary fiber intake and hepatic steatosis: insights from NHANES.
   BMC Gastroenterol. 2024;24:160.
   PubMed         Abstract available
   
   

   
   Br J Surg

8. JONES RP
   Lesional liver biopsies: better treatments, better studies, better science.
   Br J Surg. 2024;111:znae063.
   PubMed        
   
   
9. DE GRAAFF MR, Hendriks TE, Wouters M, Nielen M, et al
   Assessing quality of hepato-pancreato-biliary surgery: nationwide benchmarking.
   Br J Surg. 2024;111:znae119.
   PubMed         Abstract available
   
   

   
   Cancer Res

10. RETTIG AR, Ganesh K
    Cancer Cells Hijack Physiologic Metabolic Signals to Seed Liver Metastasis.
    Cancer Res. 2024;84:1548-1549.
    PubMed         Abstract available
    
    

    
    Dig Dis Sci

11. IM KH, Saeed WK, Kim EB, Lee AH, et al
    Deletion of Mixed Lineage Kinase Domain Like Pseudokinase Aggravates Chronic Alcohol-Induced Liver Injury via Increasing Apoptosis.
    Dig Dis Sci. 2024;69:1701-1713.
    PubMed         Abstract available
    
    
12. DONG Y, Xu H, Zhang Z, Zhou Z, et al
    A Novel Nomogram for Predicting Early Rebleeding After Endoscopic Treatment of Esophagogastric Variceal Hemorrhage.
    Dig Dis Sci. 2024;69:1852-1862.
    PubMed         Abstract available
    
    

    
    Endoscopy

13. OGURA T, Okuda A, Ueno S, Nishioka N, et al
    Endoscopic ultrasound-guided hepaticogastrostomy stent exchange using a novel spiral plastic stent.
    Endoscopy. 2024;56.
    PubMed        
    
    

    
    Gastroenterology

14. CHANG M, Hammami MB, Sakiani S
    A Case of Hepatobiliary Challenges: Unraveling the Mystery of Bile Duct Disappearance.
    Gastroenterology. 2024 May 14:S0016-5085(24)04914.
    PubMed        
    
    

    
    Gut

15. WEN J, Zhang X, Wong CC, Zhang Y, et al
    Targeting squalene epoxidase restores anti-PD-1 efficacy in metabolic dysfunction-associated steatohepatitis-induced hepatocellular carcinoma.
    Gut. 2024 May 13:gutjnl-2023-331117. doi: 10.1136/gutjnl-2023-331117.
    PubMed         Abstract available
    
    
16. ISRAELSEN M, Alvarez-Silva C, Madsen BS, Hansen CD, et al
    Impact of acute alcohol consumption on circulating microbiome in asymptomatic alcohol-related liver disease.
    Gut. 2024;73:1041-1044.
    PubMed        
    
    
17. GEIER A, Trost J, Wang K, Schmid C, et al
    PNPLA3 fatty liver allele was fixed in Neanderthals and segregates neutrally in humans.
    Gut. 2024;73:1008-1014.
    PubMed         Abstract available
    
    

    
    Hepatology

18. AFONSO MB, Marques V, van Mil SWC, Rodrigues CMP, et al
    Human liver organoids: From generation to applications.
    Hepatology. 2024;79:1432-1451.
    PubMed         Abstract available
    
    
19. JIN Y, Shou Y, Lei Q, Du C, et al
    An entropy weight method to integrate big omics and mechanistically evaluate DILI.
    Hepatology. 2024;79:1264-1278.
    PubMed         Abstract available
    
    
20. WANG A, Blackford AL, Behling C, Wilson LA, et al
    Development of Fibro-PeN, a clinical prediction model for moderate-to-severe fibrosis in children with nonalcoholic fatty liver disease.
    Hepatology. 2024;79:1381-1392.
    PubMed         Abstract available
    
    
21. UMBAUGH DS, Nguyen NT, Curry SC, Rule JA, et al
    The chemokine CXCL14 is a novel early prognostic biomarker for poor outcome in acetaminophen-induced acute liver failure.
    Hepatology. 2024;79:1352-1364.
    PubMed         Abstract available
    
    
22. SIDALI S, Borie R, Sicre de Fontbrune F, El Husseini K, et al
    Liver disease in germline mutations of telomere-related genes: Prevalence, clinical, radiological, pathological features, outcome, and risk factors.
    Hepatology. 2024;79:1365-1380.
    PubMed         Abstract available
    
    
23. SCHMIDT KA, Simonetto DA
    The telomere tango: Liver disease in the genomic spotlight.
    Hepatology. 2024;79:1249-1251.
    PubMed        
    
    
24. ZHAO G, Ma Q, Yang H, Jiang H, et al
    Base editing of the mutated TERT promoter inhibits liver tumor growth.
    Hepatology. 2024;79:1310-1323.
    PubMed         Abstract available
    
    
25. ENGSTROM A, Wintzell V, Melbye M, Svanstrom H, et al
    Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
    Hepatology. 2024;79:1401-1411.
    PubMed         Abstract available
    
    
26. ABDELMALEK MF, Rinella ME
    Steatotic liver disease, a useful construct in primary care that doesn't upset the apple cart.
    Hepatology. 2024;79:1252-1254.
    PubMed        
    
    
27. HANSEN BE, Vandriel SM, Vig P, Garner W, et al
    Event-free survival of maralixibat-treated patients with Alagille syndrome compared to a real-world cohort from GALA.
    Hepatology. 2024;79:1279-1292.
    PubMed         Abstract available
    
    
28. YEH JG, Newsome PN
    Association of glucagon-like peptide-1 receptor agonists with serious liver events among patients with type 2 diabetes: A Scandinavian cohort study.
    Hepatology. 2024;79:1255-1257.
    PubMed        
    
    
29. CALZADILLA-BERTOT L, Jeffrey AW, Jeffrey GP
    Letter to the Editor: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Hepatology. 2024;79:E153-E154.
    PubMed        
    
    
30. LOMBARDI R, Dalbeni A, Mantovani A, Ravaioli F, et al
    Reply: AGILE 3+ score, enhancing the diagnostic accuracy of advanced fibrosis in patients with nonalcoholic fatty liver disease.
    Hepatology. 2024;79:E155-E156.
    PubMed        
    
    
31. LI Z, Zhang Y, Li Y, Lan J, et al
    Letter to the Editor: Statins as potential confounding factors to investigate the association between the use of GLP-1 receptor agonists and risk of HCC.
    Hepatology. 2024;79:E169-E170.
    PubMed        
    
    
32. 
    Hepatology Highlights.
    Hepatology. 2024;79:1239-1240.
    PubMed        
    
    
33. 
    Erratum: Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3.
    Hepatology. 2024;79:E171-E172.
    PubMed        
    
    

    
    Indian J Gastroenterol

34. KUMAR S, Irtaza M, Patra BR, Rao PK, et al
    Clinical profile of adult and pediatric patients with hepatic Wilson's disease.
    Indian J Gastroenterol. 2024 May 10. doi: 10.1007/s12664-024-01586.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

35. FICHTINGER RS, Aldrighetti LA, Abu Hilal M, Troisi RI, et al
    Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial.
    J Clin Oncol. 2024;42:1799-1809.
    PubMed         Abstract available
    
    

    
    J Comput Assist Tomogr

36. DI STASIO M, Cordopatri C, Nardi C, Busoni S, et al
    Liver Biliary Function Evaluation on a 1.5T Magnetic Resonance Imaging Scan by T1 Reduction Rate Assessment Using Variable-Flip-Angle Sequences.
    J Comput Assist Tomogr. 2024;48:354-360.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

37. LIU S, Gou H, Wei H, Chen S, et al
    Cholecystohepatic shunt pathway reduces secondary bile acid accumulation to enhance natural killer T cell-mediated anti-hepatocellular carcinoma immunity.
    J Gastroenterol Hepatol. 2024 May 15. doi: 10.1111/jgh.16548.
    PubMed         Abstract available
    
    

    
    J Hepatol

38. YANG M, Zhang F, Liu K
    Cirrhosis Decompensation: Clinical and Prognostic Analysis from a New Perspective.
    J Hepatol. 2024 May 9:S0168-8278(24)00337-4. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    
39. ZHANG Y, Xiao F, Xie R
    Healthy volunteer bias for the role of genetic risk in dietary effects on hepatic steatosis, inflammation and fibrosis.
    J Hepatol. 2024 May 9:S0168-8278(24)00335-0. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    
40. NARDELLI S, Vizzutti F, Marra F, Schepis F, et al
    Can we really advise a patient undergoing TIPS that the onset of episodic hepatic encephalopathy will not influence his/her survival?
    J Hepatol. 2024 May 9:S0168-8278(24)00339-8. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    
41. ZHU CX, Yan K, Chen L, Huang RR, et al
    Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8(+) T cells in hepatocellular carcinoma.
    J Hepatol. 2024 May 15:S0168-8278(24)00342-8. doi: 10.1016/j.jhep.2024.
    PubMed         Abstract available
    
    
42. VARGHESE J, Chapiro J
    ChatGPT: The transformative influence of generative AI on science and healthcare.
    J Hepatol. 2024;80:977-980.
    PubMed         Abstract available
    
    
43. ZHANG Y, Liu H, Sheng B, Tham YC, et al
    Preliminary fatty liver disease grading using general-purpose online large language models: ChatGPT-4 or Bard?
    J Hepatol. 2024;80:e279-e281.
    PubMed        
    
    
44. KRUK B, Liebe R, Weber SN, Milkiewicz P, et al
    ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort.
    J Hepatol. 2023 Nov 28:S0168-8278(23)05290-X. doi: 10.1016/j.jhep.2023.
    PubMed        
    
    
45. HE C, Lu D, Zheng S, Xu X, et al
    Liver disease is a significant risk factor for cardiovascular outcomes - A UK Biobank study.
    J Hepatol. 2024;80:e287-e288.
    PubMed        
    
    
46. HAHN M, Herber A, Berg T, Seehofer D, et al
    Enhancing HCC Recurrence Prediction after Liver Transplantation: from DCP plus AFP-L3 model to GALAD Score.
    J Hepatol. 2023 Dec 16:S0168-8278(23)05357-6. doi: 10.1016/j.jhep.2023.
    PubMed        
    
    
47. PANG Y, Aberg F, Chen Z, Li L, et al
    Predicting risk of chronic liver disease in Chinese adults: External validation of the CLivD score.
    J Hepatol. 2024;80:e264-e266.
    PubMed        
    
    
48. COLAPIETRO F, Akpinar R, Pugliese N, Di Tommaso L, et al
    Unexpected diagnosis in females with abnormal liver ultrasound.
    J Hepatol. 2024;80:e243-e245.
    PubMed        
    
    
49. DUIJZER R, Boerrigter MM, Gevers TJG, Drenth JPH, et al
    The pathophysiology of polycystic liver disease.
    J Hepatol. 2024;80:981-983.
    PubMed        
    
    
50. BROUWERS MCGJ, Cassiman D
    Rare monogenic causes of steatotic liver disease masquerading as MASLD.
    J Hepatol. 2024;80:e252-e253.
    PubMed        
    
    
51. HASHIDA R, Nakano D, Kawaguchi M, Younossi ZM, et al
    Changing from NAFLD to MASLD: The implications for health-related quality of life data.
    J Hepatol. 2024;80:e249-e251.
    PubMed        
    
    
52. NORMAN JS, Mehta N
    Reply to: "Enhancing HCC recurrence prediction after liver transplantation: From DCP plus AFP-L3 model to GALAD score".
    J Hepatol. 2024;80:e273-e274.
    PubMed        
    
    
53. DAI H, Zhu C, Huai Q, Xu W, et al
    Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models.
    J Hepatol. 2024;80:913-927.
    PubMed         Abstract available
    
    
54. WU XN, Wang MZ, Zhang N, Zhang W, et al
    Sex-determining region Y gene promotes liver fibrosis and accounts for sexual dimorphism in its pathophysiology.
    J Hepatol. 2024;80:928-940.
    PubMed         Abstract available
    
    
55. ZOU Z, Liu X, Yu J, Ban T, et al
    Nuclear miR-204-3p mitigates metabolic dysfunction-associated steatotic liver disease in mice.
    J Hepatol. 2024;80:834-845.
    PubMed         Abstract available
    
    
56. CABIBBO G, Celsa C, Rimassa L, Torres F, et al
    Navigating the landscape of liver cancer management: Study designs in clinical trials and clinical practice.
    J Hepatol. 2024;80:957-966.
    PubMed         Abstract available
    
    
57. TANG R, Li Y, Chen R, Ma X, et al
    Reply to "ARID3A variant and the risk of primary biliary cholangitis in a Central European cohort".
    J Hepatol. 2024 Jan 30:S0168-8278(24)00058-8. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    

    
    N Engl J Med

58. NAJEM M, Dong E
    Esophageal Varices, White-Nipple Sign, and Portal Hypertensive Gastropathy.
    N Engl J Med. 2024;390:e47.
    PubMed        
    
    

    
    PLoS One

59. VATSYAYAN A, Kumar M, Saikia BJ, Scaria V, et al
    WilsonGenAI a deep learning approach to classify pathogenic variants in Wilson Disease.
    PLoS One. 2024;19:e0303787.
    PubMed         Abstract available
    
    
60. OSAWA Y, Kawai H, Nakashima K, Nakaseko Y, et al
    Sphingosine-1-phosphate promotes liver fibrosis in metabolic dysfunction-associated steatohepatitis.
    PLoS One. 2024;19:e0303296.
    PubMed         Abstract available
    
    

    
    Radiology

61. MENDIRATTA-LALA M, Fetzer D, Kamaya A, Parikh ND, et al
    The Future Role of Abdominal US in Hepatocellular Carcinoma Surveillance.
    Radiology. 2024;311:e232624.
    PubMed         Abstract available
    
    
62. OZKAYA E, Kennedy P, Chen J, Bane O, et al
    Precision and Test-Retest Repeatability of Stiffness Measurement with MR Elastography: A Multicenter Phantom Study.
    Radiology. 2024;311:e233136.
    PubMed         Abstract available
    
    
63. TANG A
    Liver Stiffness at MR Elastography: A Surrogate Biomarker for Staging Liver Fibrosis, Predicting Clinical Outcomes, and Selecting Patients.
    Radiology. 2024;311:e240890.
    PubMed        
    
    

    
    Semin Liver Dis

64. MA J, Bjornsson ES, Chalasani N
    Hepatotoxicity of Antibiotics and Antifungals and Their Safe Use in Hepatic Impairment.
    Semin Liver Dis. 2024 May 13. doi: 10.1055/s-0044-1787062.
    PubMed         Abstract available
    
    

    
    Transplant Proc

65. SILVA MS, Waisberg DR, Caldas TG, Martino RB, et al
    Life-Threatening Ruptured Hepatic Artery Pseudoaneurysm Post-Liver Transplant: A Case Report.
    Transplant Proc. 2024 May 13:S0041-1345(24)00256.
    PubMed         Abstract available
    
    

    
    Transplantation

66. CILLO U, Lauterio A, Furlanetto A, Canitano N, et al
    Full-left/Full-right Liver Splitting With Middle Hepatic Vein and Caval Partition During Dual Hypothermic Oxygenated Machine Perfusion.
    Transplantation. 2024 May 17. doi: 10.1097/TP.0000000000005039.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.